NVAX FY 2009 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$325,000-69.5% YoY

Gross Profit

$325,000100.0% margin

Operating Income

-$37M-11502.5% margin

Net Income

-$38M-11807.4% margin

EPS (Diluted)

$-8.97

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$86M

Total Liabilities

$11M

Stockholders' Equity

$74M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$325,000	$1M	-69.5%
Gross Profit	$325,000	$1M	-69.5%
Operating Income	-$37M	-$34M	-8.8%
Net Income	-$38M	-$36M	-6.4%